Structural impact of arrested foveal development in children born extremely preterm without ROP at 6.5 years of age.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 08 04 2022
accepted: 01 09 2022
revised: 02 08 2022
medline: 19 6 2023
pubmed: 17 9 2022
entrez: 16 9 2022
Statut: ppublish

Résumé

To characterize changes of foveal topography and microstructure of persisting foveal immaturity at 6.5 years of age in children born extremely preterm without retinopathy of prematurity (EPT-NoROP). Images from previous optical coherence tomography examinations of 37 EPT-NoROP and 92 control eyes were selected from a regional cohort of the EXPRESS (Extremely Preterm Infants in Sweden) study. Thickness of ganglion cell + inner plexiform layer (GCL+), outer nuclear layer (ONL), retinal thickness (RT) at the foveal centre (FC), foveal depth (FD) and RT at the foveal rim were evaluated. Layer thickness of GCL+, ONL and RT was increased at FC in the EPT-NoROP group. More than two-thirds had thickness values above the control limit (control mean +2 SD) at FC (GCL + 68%, ONL 76%, and RT 68%), and 50% had reduced FD compared to controls. All parameters showed a high correlation within the EPT-NoROP group, whereas no or weaker correlation was seen in control eyes. The EPT-NoROP sub-groups, divided based on the control limit, did not differ in terms of associated factors such as gestational age, birth weight, visual acuity, and refraction. Extreme prematurity without impact of ROP is associated with increased GCL + , ONL, and RT thickness at FC as well as reduced FD compared to full-term controls at age 6.5. This indicates that prematurity per se may have a profound effect on foveal anatomical maturation during the first months after birth. Our results suggest RT at FC to be a simple and useful measure of foveal anatomical immaturity.

Identifiants

pubmed: 36114289
doi: 10.1038/s41433-022-02237-6
pii: 10.1038/s41433-022-02237-6
pmc: PMC10276016
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1810-1815

Informations de copyright

© 2022. The Author(s).

Références

Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5105-10
pubmed: 21803966
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4537-45
pubmed: 26200492
Retina. 2017 Dec;37(12):2281-2288
pubmed: 28098724
JAMA Ophthalmol. 2016 May 01;134(5):555-562
pubmed: 27010699
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):4948-4958
pubmed: 28973368
Eye (Lond). 2018 Jan;32(1):104-112
pubmed: 28776594
Br J Ophthalmol. 2011 Jun;95(6):799-803
pubmed: 20974631
Am J Ophthalmol. 2012 Nov;154(5):767-778.e2
pubmed: 22935600
Retina. 2020 Aug;40(8):1592-1602
pubmed: 31356497
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT235-41
pubmed: 27409477
Ophthalmology. 2012 Sep;119(9):1907-16
pubmed: 22578258
JAMA. 2009 Jun 3;301(21):2225-33
pubmed: 19491184
Indian J Ophthalmol. 2019 Jun;67(6):846-853
pubmed: 31124500
Retina. 2020 Jul;40(7):1344-1352
pubmed: 31157715
Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):25
pubmed: 33599735
Am J Ophthalmol. 2012 Nov;154(5):779-789.e2
pubmed: 22898189
Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):28
pubmed: 32936301
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT550-5
pubmed: 27537414
Graefes Arch Clin Exp Ophthalmol. 2021 Oct;259(10):3137-3148
pubmed: 33961109
Br J Ophthalmol. 2012 Jul;96(7):961-6
pubmed: 22544530
Ophthalmic Physiol Opt. 2015 Jul;35(4):433-41
pubmed: 26094832
Ophthalmology. 2019 Jan;126(1):107-112
pubmed: 30092239
Prog Retin Eye Res. 2013 Jul;35:63-81
pubmed: 23500068
JAMA Pediatr. 2016 Oct 01;170(10):954-963
pubmed: 27479919
Eye (Lond). 2020 Jun;34(6):1077-1085
pubmed: 31645674
Invest Ophthalmol Vis Sci. 2008 May;49(5):2061-70
pubmed: 18223243

Auteurs

Abinaya Priya Venkataraman (AP)

Department of Clinical Neuroscience, Division of Eye and Vision, Unit of Optometry, Karolinska Institutet, Stockholm, Sweden. abinaya.venkataraman@ki.se.

Zoran Popovic (Z)

Section of Ophthalmology, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Ophthalmology, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.

Kerstin Hellgren (K)

Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden.
Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.

Johan Sjöstrand (J)

Section of Ophthalmology, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Maria Nilsson (M)

Department of Clinical Neuroscience, Division of Eye and Vision, Unit of Optometry, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH